AstraZeneca PLC
NASDAQ:AZN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.03
87.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
AZN Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for AZN is 92.3 USD with a low forecast of 42.82 USD and a high forecast of 139.84 USD.
AZN Last Price Targets
AstraZeneca PLC
The latest public price target was made on Sep 11, 2024 by
Etzer Darout
from
BMO Capital
,
who expects
AZN
stock to
rise by 14%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Etzer Darout
BMO Capital
|
89
USD
Upside 14% |
1 month ago
Sep 11, 2024
|
BMO Capital Reiterates Outperform Rating on AstraZeneca (AZN)
StreetInsider
|
John Eade
Argus Research
|
85
USD
Upside 9% |
4 months ago
May 30, 2024
|
AstraZeneca (AZN) PT Raised to $85 at Argus
StreetInsider
|
|
Etzer Darout
BMO Capital
|
82
USD
Upside 5% |
4 months ago
May 28, 2024
|
BMO Capital Reiterates Outperform Rating on AstraZeneca (AZN)
StreetInsider
|
|
Andrew Berens
Leerink Partners
|
79
USD
Upside 1% |
1 year ago
Jul 12, 2023
|
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AZN's stock price target?
Price Target
92.3
USD
According to Wall Street analysts, the average 1-year price target for AZN is 92.3 USD with a low forecast of 42.82 USD and a high forecast of 139.84 USD.
What is AstraZeneca PLC's Revenue forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for AstraZeneca PLC's revenue is 8%. The projected CAGR for the next 3 years is 10%.
What is AstraZeneca PLC's Operating Income forecast?
Projected CAGR
32%
For the last 8 years the compound annual growth rate for AstraZeneca PLC's operating income is 6%. The projected CAGR for the next 3 years is 32%.
What is AstraZeneca PLC's Net Income forecast?
Projected CAGR
40%
For the last 8 years the compound annual growth rate for AstraZeneca PLC's net income is 10%. The projected CAGR for the next 3 years is 40%.
You don't have any saved screeners yet
